Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Gabriela Ortiz‐Soto"'
Publikováno v:
Pharmaceuticals, Vol 17, Iss 3, p 326 (2024)
SMADs are the canonical intracellular effector proteins of the TGF-β (transforming growth factor-β). SMADs translocate from plasma membrane receptors to the nucleus regulated by many SMAD-interacting proteins through phosphorylation and other post-
Externí odkaz:
https://doaj.org/article/9b1c349711f3436e99d23b8a53c99b62
Autor:
Astrid Zayas‐Santiago, Michelle M. Martínez‐Montemayor, Jadier Colón‐Vázquez, Gabriela Ortiz‐Soto, Jose G. Cirino‐Simonet, Mikhail Inyushin
Publikováno v:
FEBS Open Bio, Vol 12, Iss 1, Pp 95-105 (2022)
Accumulation of amyloid in breast cancer is a well‐known phenomenon, but only immunoglobulin light‐chain amyloidosis (AL) or transthyretin (TTR) amyloid had been detected in human breast tumor samples previously. We recently reported that another
Externí odkaz:
https://doaj.org/article/f1f4d27d61af44028cff34f3e0161032
Autor:
Michelle M. Martínez-Montemayor, Taotao Ling, Ivette J. Suárez-Arroyo, Gabriela Ortiz-Soto, Camille L. Santiago-Negrón, Mercedes Y. Lacourt-Ventura, Anibal Valentín-Acevedo, Walter H. Lang, Fatima Rivas
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
We previously reported that Ganoderma lucidum extract (GLE) demonstrate significant anti-cancer activity against triple negative inflammatory breast cancer models. Herein, we aimed to elucidate the bioactive compounds of GLE responsible for this anti
Externí odkaz:
https://doaj.org/article/d007338dd510499e9c088d509da2d89c
Autor:
Cameron Geller, Joanna Maddela, Ranel Tuplano, Farhana Runa, Yvess Adamian, Robert Güth, Gabriela Ortiz Soto, Luke Tomaneng, Joseph Cantor, Jonathan A. Kelber
Extracellular matrix (ECM) protein expression/deposition within and stiffening of the breast cancer microenvironment facilitates disease progression and correlates with poor patient survival. However, the mechanisms by which ECM components control tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25dcc9f39960b1d637ad9073f559d9dd
https://doi.org/10.1101/2023.04.13.536765
https://doi.org/10.1101/2023.04.13.536765
Autor:
Jose G. Cirino-Simonet, Mikhail Inyushin, Michelle M. Martínez-Montemayor, Gabriela Ortiz-Soto, Jadier Colón-Vázquez, Astrid Zayas-Santiago
Publikováno v:
FEBS Open Bio, Vol 12, Iss 1, Pp 95-105 (2022)
FEBS Open Bio
FEBS Open Bio
Accumulation of amyloid in breast cancer is a well‐known phenomenon, but only immunoglobulin light‐chain amyloidosis (AL) or transthyretin (TTR) amyloid had been detected in human breast tumor samples previously. We recently reported that another
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72298ca2dd272269d3af35c624e2601c
https://doaj.org/article/f1f4d27d61af44028cff34f3e0161032
https://doaj.org/article/f1f4d27d61af44028cff34f3e0161032
Autor:
Gabriela Ortiz-Soto, Natalia S. Babilonia-Díaz, Mercedes Y. Lacourt-Ventura, Delmarie M. Rivera-Rodríguez, Jailenne I. Quiñones-Rodríguez, Mónica Colón-Vargas, Israel Almodóvar-Rivera, Luis E. Ferrer-Torres, Ivette J. Suárez-Arroyo, Michelle M. Martínez-Montemayor
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 5
Pages: 4694
Volume 24
Issue 5
Pages: 4694
Inflammatory breast cancer (IBC) is one of the most lethal subtypes of breast cancer (BC), accounting for approximately 1–5% of all cases of BC. Challenges in IBC include accurate and early diagnosis and the development of effective targeted therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2484fe9b5000f6359b767a17bd0bbb
Autor:
Ariana C Acevedo-Diaz, Gabriela Ortiz-Soto, Ivette J. Suarez-Arroyo, Michelle M. Martínez Montemayor, Astrid Zayas-Santiago
Publikováno v:
Nutrients
Nutrients, Vol 11, Iss 5, p 1116 (2019)
Nutrients, Vol 11, Iss 5, p 1116 (2019)
Breast cancer (BC) is the second leading cause of cancer death among women worldwide. The main cause of BC morbidity and mortality is the invasiveness capacity of cancer cells that may lead to metastasis. Here, we aimed to investigate the therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf98b6d00b3acbfeedb338bd69b02638
http://europepmc.org/articles/PMC6567024
http://europepmc.org/articles/PMC6567024
Publikováno v:
Cancer Research. 80:5918-5918
Inflammatory breast cancer (IBC) is the most lethal form of breast cancer where patients display a lower 5-year survival rate. The lethality of IBC originates from its nature of invading the vascular and lymphatic systems, absence of a tumor mass, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0c14000a00f2c5eb5b450efaf3b2d2c
https://doi.org/10.1158/1538-7445.am2020-5918
https://doi.org/10.1158/1538-7445.am2020-5918
Publikováno v:
The FASEB Journal. 34:1-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7804ea1a452cf4269e89c943f86007e7
https://doi.org/10.1096/fasebj.2020.34.s1.04705
https://doi.org/10.1096/fasebj.2020.34.s1.04705
Autor:
Michelle M, Martínez-Montemayor, Taotao, Ling, Ivette J, Suárez-Arroyo, Gabriela, Ortiz-Soto, Camille L, Santiago-Negrón, Mercedes Y, Lacourt-Ventura, Anibal, Valentín-Acevedo, Walter H, Lang, Fatima, Rivas
Publikováno v:
Frontiers in Pharmacology
We previously reported that Ganoderma lucidum extract (GLE) demonstrate significant anti-cancer activity against triple negative inflammatory breast cancer models. Herein, we aimed to elucidate the bioactive compounds of GLE responsible for this anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7f347dae769bb24c0ab9bb88171d429
https://pubmed.ncbi.nlm.nih.gov/30837881
https://pubmed.ncbi.nlm.nih.gov/30837881